Results 21 to 30 of about 1,349 (113)
Delayed diagnosis of X-linked agammaglobulinaemia in a boy with recurrent meningitis
Background X-linked agammaglobulinaemia (XLA) is a rare inherited primary immunodeficiency disease characterized by the B cell developmental defect, caused by mutations in the gene coding for Bruton’s tyrosine kinase (BTK), which may cause serious ...
Ya-Ni Zhang +7 more
doaj +1 more source
Invasive Aspergillosis in Patients Treated With Ibrutinib
HemaSphere, Volume 4, Issue 2, April 2020.
Moritz Fürstenau +6 more
wiley +1 more source
Effects of BTK signalling in pathogenic microorganism infections
Abstract As a cytoplasmic protein tyrosine kinase, Bruton's tyrosine kinase (Btk) is widely considered as a vital kinase in many aspects of different physiologic processes. It is engaged in many important signalling pathways related to the immune response, such as the B cell receptor pathway, pattern‐recognition receptor pathway, and triggering ...
Bingjue Ye +3 more
wiley +1 more source
Disseminated Cryptococcal Disease in a Patient with Chronic Lymphocytic Leukemia on Ibrutinib
Cryptococcus is a unique environmental fungus that can cause disease most often in immunocompromised individuals with defective cell‐mediated immunity. Chronic lymphocytic leukemia (CLL) is not known to be a risk factor for cryptococcal disease although cases have been described mainly in patients treated with agents that suppress cell‐mediated ...
Koh Okamoto +3 more
wiley +1 more source
Itk: The Rheostat of the T Cell Response
The nonreceptor tyrosine kinase Itk plays a key role in TCR‐initiated signaling that directly and significantly affects the regulation of PLCγ1 and the consequent mobilization of Ca2+. Itk also participates in the regulation of cytoskeletal reorganization as well as cellular adhesion, which is necessary for a productive T cell response.
Juris A. Grasis +2 more
wiley +1 more source
Low dose Btk inhibitors selectively block platelet activation by CLEC-2 [PDF]
Inhibitors of the tyrosine kinase Btk have been proposed as novel antiplatelet agents. In this study we show that low concentrations of the Btk inhibitor ibrutinib block CLEC-2-mediated activation and tyrosine phosphorylation including Syk and PLCγ2 in ...
Joana Campos +53 more
core +1 more source
Identification of Btk mutations in 20 unrelated patients with X-Iinked agammaglobulinaemia (XLA)
X-linked agammaglobulinaemia (XLA) is an inherited immunodeficiency resulting from mutations in the gene for a cytoplasmic protein tyrosine kinase (Btk).
Vorechovsky, lgor +19 more
core +1 more source
A role for Bruton's tyrosine kinase (Btk) in platelet activation by collagen
Bruton's tyrosine kinase (Btk) is essential for normal B-cell receptor signalling. The lack of expression of functional Btk in humans leads to the B-cell deficiency X-linked agammaglobulinaemia (XLA).
Bolen, J., Quek, L.S., Watson, S.P.
core +1 more source
Summary Recently we reported that monocyte phagocytosis and chemotaxis are impaired in X-linked agammaglobulinaemia (XLA) and common variable immunodeficiency (CVI) patients.
M T N Da Silva +5 more
core +2 more sources
Absence of Bruton's tyrosine kinase (Btk) mutations in patients with acute myeloid leukaemia
Bruton's tyrosine kinase (Btk) is a non-receptor protein tyrosine kinase (PTK) that is expressed in all haemopoietic lineages except mature T cells and plasma cells. Despite the broad range of expression.
Kanariou, M +14 more
core +1 more source

